Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Encapsulated dexamethasone as a steroid-sparing alternative after double lung transplantation in cystic fibrosis
2011-000130-11Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexamethasone sodium phosphate in Lung allograft rejection (LAR) and cystic fibrosis (CF) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Prevention of acute or chronic rejection. Started Mar 2012; status: active.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
Lung allograft rejection (LAR)cystic fibrosis (CF)
Beyond the preview
Go deeper on 2011-000130-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000130-11.